
21.20 Delayed Data As of May 18 | ![]() Today’s Change | 18.98 Today|||52-Week Range 36.95 | -23.19% Year-to-Date |
Myriad Genetics (MYGN) Reports Loss in Q1, Gross Margin Down May 06 / Zacks.com - Paid Partner Content |
Previous close | 22.65 |
Today’s open | 22.11 |
Day’s range | 21.01 - 22.60 |
Volume | 802,800 |
Average volume (3 months) | 548,876 |
Market cap | $1.8B |
Earnings growth (last year) | +87.01% |
Earnings growth (this year) | -1,050.00% |
Earnings growth (next 5 years) | +6.00% |
Revenue growth (last year) | +8.14% |
P/E ratio | NM |
Price/Sales | 3.12 |
Price/Book | 1.85 |
Next reporting date | August 2, 2022 |
EPS forecast (this quarter) | $0.03 |
Annual revenue (last year) | $690.6M |
Annual profit (last year) | -$27.2M |
Net profit margin | -3.94% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |